These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28865079)

  • 1. Acquired erythropoietic uroporphyria secondary to myelodysplastic syndrome with chromosome 3 alterations: a case report.
    Podlipnik S; Guijarro F; Combalia A; To-Figueras J; Badenas C; Costa D; Rozman M; Jorge S; Aguilera P; Gaya A
    Br J Dermatol; 2018 Aug; 179(2):486-490. PubMed ID: 28865079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietic uroporphyria associated with myeloid malignancy is likely distinct from autosomal recessive congenital erythropoietic porphyria.
    Sarkany RP; Ibbotson SH; Whatley SD; Lawrence CM; Gover P; Mufti GJ; Murphy GM; Masters GS; Badminton MN; Elder GH
    J Invest Dermatol; 2011 May; 131(5):1172-5. PubMed ID: 21326293
    [No Abstract]   [Full Text] [Related]  

  • 3. Congenital erythropoietic porphyria associated with myelodysplasia presenting in a 72-year-old man: report of a case and review of the literature.
    Kontos AP; Ozog D; Bichakjian C; Lim HW
    Br J Dermatol; 2003 Jan; 148(1):160-4. PubMed ID: 12534613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5'-azacitidine in myelodysplastic syndromes with inversion of chromosome 3.
    Breccia M; Cannella L; Santopietro M; Loglisci G; Federico V; Salaroli A; Nanni M; Mancini M; Alimena G
    Leukemia; 2011 Apr; 25(4):736-7. PubMed ID: 21293489
    [No Abstract]   [Full Text] [Related]  

  • 5. Late-onset cutaneous porphyria in a patient heterozygous for a uroporphyrinogen III synthase gene mutation.
    Aguilera P; Badenas C; Whatley SD; To-Figueras J
    Br J Dermatol; 2016 Dec; 175(6):1346-1350. PubMed ID: 27086902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Allogeneic bone marrow transplantation in congenital erythropoietic porphyria. Gunther's disease].
    Lagarde C; Hamel-Teillac D; De Prost Y; Blanche S; Thomas C; Fischer A; Nordmann Y; Ged C; De Verneuil H
    Ann Dermatol Venereol; 1998 Feb; 125(2):114-7. PubMed ID: 9747227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Very Early Diagnosis and Management of Congenital Erythropoietic Porphyria.
    Desjardins MP; Naccache L; Hébert A; Auger I; Teira P; Pelland-Marcotte MC
    Clin Pediatr (Phila); 2023 Jun; 62(5):399-403. PubMed ID: 36217751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Congenital erythropoietic porphyria: case report and management recommendations].
    Salomone B C; Ogueta C I; Reyes V C; Durán S G; Aguirre N; Wietstruck A
    Arch Argent Pediatr; 2018 Apr; 116(2):e300-e302. PubMed ID: 29557620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A knock-in mouse model of congenital erythropoietic porphyria.
    Ged C; Mendez M; Robert E; Lalanne M; Lamrissi-Garcia I; Costet P; Daniel JY; Dubus P; Mazurier F; Moreau-Gaudry F; de Verneuil H
    Genomics; 2006 Jan; 87(1):84-92. PubMed ID: 16314073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction of congenital erythropoietic porphyria by bone marrow transplantation.
    Thomas C; Ged C; Nordmann Y; de Verneuil H; Pellier I; Fischer A; Blanche S
    J Pediatr; 1996 Sep; 129(3):453-6. PubMed ID: 8804339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azacitidine treatment for patients with myelodysplastic syndrome and acute myeloid leukemia with chromosome 3q abnormalities.
    Wanquet A; Prebet T; Berthon C; Sebert M; Roux C; Kulasekararaj A; Micol JB; Esterni B; Itzykson R; Thepot S; Recher C; Delaunay J; Dreyfus F; Mufti G; Fenaux P; Vey N
    Am J Hematol; 2015 Oct; 90(10):859-63. PubMed ID: 26113240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful match-unrelated donor bone marrow transplantation for congenital erythropoietic porphyria (Günther disease).
    Dupuis-Girod S; Akkari V; Ged C; Galambrun C; Kebaïli K; Deybach JC; Claudy A; Geburher L; Philippe N; de Verneuil H; Bertrand Y
    Eur J Pediatr; 2005 Feb; 164(2):104-7. PubMed ID: 15703981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired erythropoietic uroporphyria associated with clonal cytopenia of undetermined significance.
    Swanson LA; Johannsson F; Tortorelli S; Yi CA; Shah S
    JAAD Case Rep; 2023 Feb; 32():44-47. PubMed ID: 36687304
    [No Abstract]   [Full Text] [Related]  

  • 14. Bone marrow erythroid cell inclusions reveal congenital erythropoietic porphyria.
    Saultier P; Loosveld M; Arnoux I; Tosello B; Quessada J; Barlogis V
    Br J Haematol; 2021 Oct; 195(2):153. PubMed ID: 34114205
    [No Abstract]   [Full Text] [Related]  

  • 15. Acquired erythropoietic uroporphyria and myelodysplastic syndrome cured by bone marrow transplantation.
    de Verneuil H
    Br J Dermatol; 2018 Aug; 179(2):256-257. PubMed ID: 30141566
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of severe congenital erythropoietic porphyria by bone marrow transplantation.
    Harada FA; Shwayder TA; Desnick RJ; Lim HW
    J Am Acad Dermatol; 2001 Aug; 45(2):279-82. PubMed ID: 11464191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment by azacitidine therapy of intestinal Behçet's disease associated with myelodysplastic syndrome.
    Tanaka H; Shimizu N; Tougasaki E; Kawajiri C; Hashimoto S; Takeda Y; Sakai S; Takeuchi M; Ohwada C; Sakaida E; Takagi T; Nakaseko C
    Int J Hematol; 2013 Apr; 97(4):520-4. PubMed ID: 23519573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late-onset erythropoietic porphyria caused by a chromosome 18q deletion in erythroid cells.
    Aplin C; Whatley SD; Thompson P; Hoy T; Fisher P; Singer C; Lovell CR; Elder GH
    J Invest Dermatol; 2001 Dec; 117(6):1647-9. PubMed ID: 11886534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelodysplastic syndromes: 2015 Update on diagnosis, risk-stratification and management.
    Garcia-Manero G
    Am J Hematol; 2015 Sep; 90(9):831-41. PubMed ID: 26294090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in understanding the pathogenesis of congenital erythropoietic porphyria.
    Di Pierro E; Brancaleoni V; Granata F
    Br J Haematol; 2016 May; 173(3):365-79. PubMed ID: 26969896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.